Selected research
Industry Research
Gases for Pharmaceutical and Biotechnology Industry Research Report 2026
Market perspective
The global Gases for Pharmaceutical and Biotechnology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gases for Pharmaceutical and Biotechnology is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gases for Pharmaceutical and Biotechnology is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gases for Pharmaceutical and Biotechnology is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gases for Pharmaceutical and Biotechnology include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gases for Pharmaceutical and Biotechnology market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Gases for Pharmaceutical and Biotechnology.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gases for Pharmaceutical and Biotechnology Market by Company
Air Liquide
Taiyo Nippon Sanso
Messer Group
Matheson
Air Products
Coregas
Linde
SOL Group
Gases for Pharmaceutical and Biotechnology Segment by Type
Nitrogen
Carbon Dioxide
Oxygen
Others
Gases for Pharmaceutical and Biotechnology Segment by Application
Laboratory
Pharmaceutical and Biotechnology Companies
Others
Gases for Pharmaceutical and Biotechnology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gases for Pharmaceutical and Biotechnology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gases for Pharmaceutical and Biotechnology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gases for Pharmaceutical and Biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nitrogen
- Carbon Dioxide
- Oxygen
- Others
Applications
- Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
Companies covered
- Air Liquide
- Taiyo Nippon Sanso
- Messer Group
- Matheson
- Air Products
- Coregas
- Linde
- SOL Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gases for Pharmaceutical and Biotechnology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Nitrogen
- 2.2.3 Carbon Dioxide
- 2.2.4 Oxygen
- 2.2.5 Others
- 2.3 Gases for Pharmaceutical and Biotechnology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Laboratory
- 2.3.3 Pharmaceutical and Biotechnology Companies
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Gases for Pharmaceutical and Biotechnology Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Gases for Pharmaceutical and Biotechnology Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Gases for Pharmaceutical and Biotechnology Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gases for Pharmaceutical and Biotechnology Production by Manufacturers (2021-2026)
- 3.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Manufacturers (2021-2026)
- 3.3 Global Gases for Pharmaceutical and Biotechnology Average Price by Manufacturers (2021-2026)
- 3.4 Global Gases for Pharmaceutical and Biotechnology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gases for Pharmaceutical and Biotechnology Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Gases for Pharmaceutical and Biotechnology Manufacturers, Product Type & Application
- 3.7 Global Gases for Pharmaceutical and Biotechnology Manufacturers Established Date
- 3.8 Global Gases for Pharmaceutical and Biotechnology Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Air Liquide
- 4.1.1 Air Liquide Gases for Pharmaceutical and Biotechnology Company Information
- 4.1.2 Air Liquide Gases for Pharmaceutical and Biotechnology Business Overview
- 4.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Air Liquide Product Portfolio
- 4.1.5 Air Liquide Recent Developments
- 4.2 Taiyo Nippon Sanso
- 4.2.1 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Company Information
- 4.2.2 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Business Overview
- 4.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Taiyo Nippon Sanso Product Portfolio
- 4.2.5 Taiyo Nippon Sanso Recent Developments
- 4.3 Messer Group
- 4.3.1 Messer Group Gases for Pharmaceutical and Biotechnology Company Information
- 4.3.2 Messer Group Gases for Pharmaceutical and Biotechnology Business Overview
- 4.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Messer Group Product Portfolio
- 4.3.5 Messer Group Recent Developments
- 4.4 Matheson
- 4.4.1 Matheson Gases for Pharmaceutical and Biotechnology Company Information
- 4.4.2 Matheson Gases for Pharmaceutical and Biotechnology Business Overview
- 4.4.3 Matheson Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Matheson Product Portfolio
- 4.4.5 Matheson Recent Developments
- 4.5 Air Products
- 4.5.1 Air Products Gases for Pharmaceutical and Biotechnology Company Information
- 4.5.2 Air Products Gases for Pharmaceutical and Biotechnology Business Overview
- 4.5.3 Air Products Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Air Products Product Portfolio
- 4.5.5 Air Products Recent Developments
- 4.6 Coregas
- 4.6.1 Coregas Gases for Pharmaceutical and Biotechnology Company Information
- 4.6.2 Coregas Gases for Pharmaceutical and Biotechnology Business Overview
- 4.6.3 Coregas Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Coregas Product Portfolio
- 4.6.5 Coregas Recent Developments
- 4.7 Linde
- 4.7.1 Linde Gases for Pharmaceutical and Biotechnology Company Information
- 4.7.2 Linde Gases for Pharmaceutical and Biotechnology Business Overview
- 4.7.3 Linde Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Linde Product Portfolio
- 4.7.5 Linde Recent Developments
- 4.8 SOL Group
- 4.8.1 SOL Group Gases for Pharmaceutical and Biotechnology Company Information
- 4.8.2 SOL Group Gases for Pharmaceutical and Biotechnology Business Overview
- 4.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 SOL Group Product Portfolio
- 4.8.5 SOL Group Recent Developments
5 Global Gases for Pharmaceutical and Biotechnology Production by Region
- 5.1 Global Gases for Pharmaceutical and Biotechnology Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021-2032
- 5.2.1 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021-2026
- 5.2.2 Global Gases for Pharmaceutical and Biotechnology Production Forecast by Region (2027-2032)
- 5.3 Global Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Gases for Pharmaceutical and Biotechnology Production Value by Region: 2021-2032
- 5.4.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Region: 2021-2026
- 5.4.2 Global Gases for Pharmaceutical and Biotechnology Production Value Forecast by Region (2027-2032)
- 5.5 Global Gases for Pharmaceutical and Biotechnology Market Price Analysis by Region (2021-2026)
- 5.6 Global Gases for Pharmaceutical and Biotechnology Production and Value, YOY Growth
- 5.6.1 North America Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
6 Global Gases for Pharmaceutical and Biotechnology Consumption by Region
- 6.1 Global Gases for Pharmaceutical and Biotechnology Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2021-2032)
- 6.2.1 Global Gases for Pharmaceutical and Biotechnology Consumption by Region: 2021-2026
- 6.2.2 Global Gases for Pharmaceutical and Biotechnology Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Gases for Pharmaceutical and Biotechnology Production by Type (2021-2032)
- 7.1.1 Global Gases for Pharmaceutical and Biotechnology Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2021-2032)
- 7.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021-2032)
- 7.2.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Type (2021-2032)
- 7.3 Global Gases for Pharmaceutical and Biotechnology Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Gases for Pharmaceutical and Biotechnology Production by Application (2021-2032)
- 8.1.1 Global Gases for Pharmaceutical and Biotechnology Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Application (2021-2032)
- 8.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021-2032)
- 8.2.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Application (2021-2032)
- 8.3 Global Gases for Pharmaceutical and Biotechnology Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
- 9.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Gases for Pharmaceutical and Biotechnology Production Mode & Process
- 9.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gases for Pharmaceutical and Biotechnology Distributors
- 9.2.3 Gases for Pharmaceutical and Biotechnology Customers
10 Global Gases for Pharmaceutical and Biotechnology Analyzing Market Dynamics
- 10.1 Gases for Pharmaceutical and Biotechnology Industry Trends
- 10.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
- 10.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
- 10.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst